APSR2026-549

Yes
Late-Breaking
Submitted
Oral Presentation
AO12-004
 
 
https://storage.unitedwebnetwork.com/files/1285/1219634-46903-UAT Pres - APSR_433569.pptx
Format: PPTX Only
 
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Craig Wittmer * St George Hospital Respiratory Sydney Australia
Georgia Hollens - St George Hospital Respiratory Sydney Australia
Haleem Mohammed Abdul - St George Hospital Respiratory Sydney Australia
Yizhong Zheng - St George Hospital Respiratory Sydney Australia
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Craig
Wittmer
craig.wittmer@health.nsw.gov.au
+61432122427
Under 30
Australia
Original Research
Urinary Antigen Testing in Community-Acquired Pneumonia: A Single-Centre Retrospective Cohort Study of Utilisation, Diagnostic Yield, and Clinical Impact
Maximum 25 words
Abstract Content
Urinary antigen tests (UATs) for Streptococcus pneumoniae and Legionella pneumophila are used in community-acquired pneumonia (CAP) as rapid, non-invasive diagnostics. However, prior studies demonstrate low diagnostic yield and limited impact on antibiotic management. Guidelines recommend selective use in severe disease or specific risk factors, yet testing is often performed broadly. This study evaluated the utilisation, diagnostic yield, clinical impact, and cost-effectiveness of UAT in adults admitted with CAP to a tertiary hospital in Sydney, Australia.
A retrospective audit was conducted at St George Hospital, Sydney, including adults admitted under the respiratory service with CAP between April and June 2025. Cases were defined using clinical and radiological criteria. Electronic medical records were reviewed for test utilisation, results, antibiotic management, and cost data.
A total of 135 patients were included following screening of 264 admissions. Median age was 75 years (64–84), with radiological pneumonia in 127 patients (94.1%). Pneumococcal UAT was performed in 89 patients (65.9%) and Legionella UAT in 87 (64.4%). Pneumococcal UAT was positive in 12 cases (13.5%) and Legionella in 2 (2.3%). Pneumococcal UAT led to antibiotic change in 7 cases, primarily de-escalation to benzylpenicillin; no changes were attributable to Legionella UAT. Median turnaround time was 7 hours (3.5–13). Across 176 tests, 7 resulted in antibiotic modification (number needed to test 25.1). Total cost was $7,370, equating to $601 per pathogen detected and $1,203 per antibiotic change.
UAT use was common and frequently non-selective, with testing applied broadly rather than targeted to patients with severe CAP or specific risk factors. Diagnostic yield was low, particularly for Legionella, with minimal impact on antibiotic management. Routine testing incurred substantial cost, suggesting limited value in unselected CAP populations and supporting a more targeted, severity-based approach.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Pneumonia, Urinary antigen testing, Pneumococcal
maximum 3 keywords and no abbreviations, separated by commas
 
294